Biomedicines (Apr 2022)

Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice

  • Kwan-Ling Yip,
  • Tsen-Ni Tsai,
  • I-Ping Yang,
  • Zhi-Feng Miao,
  • Yen-Cheng Chen,
  • Ching-Chun Li,
  • Wei-Chih Su,
  • Tsung-Kun Chang,
  • Ching-Wen Huang,
  • Hsiang-Lin Tsai,
  • Yung-Sung Yeh,
  • Jaw-Yuan Wang

DOI
https://doi.org/10.3390/biomedicines10050955
Journal volume & issue
Vol. 10, no. 5
p. 955

Abstract

Read online

Studies have demonstrated that metformin has antitumor effects in addition to therapeutic effects on hyperglycemia; however, few studies have explored the effects of metformin in chemotherapy. Therefore, we hypothesized that the administration of metformin would enhance the therapeutic effects of 5-fluorouracil and oxaliplatin (FuOx) to inhibit the growth of colorectal cancer (CRC) cells in vitro and in vivo. The results of our in vitro experiments demonstrated that metformin significantly increased the effects of FuOx with respect to cell proliferation (p p p p p p < 0.05). These findings demonstrate that metformin may act as an adjunctive agent to enhance the chemosensitivity of CRC cells to FuOx. However, further clinical trials are warranted to validate the clinical implications of the findings.

Keywords